Medical Research

Report

Hedging Pipeline Risk in Pharma: FDA Swaps and Annuities

The cost of capital to conduct medical R&D is high because investors must be compensated with significant returns to offset the risky and long drug-development process. This cost of capital could be reduced, and thus medical innovation...
Read Report
TP

Tomas J. Philipson

Formerly Milken Institute
Report

Financing the Control of Tuberculosis

As of 2015, roughly one third of the world’s population, mostly in poorer countries, carried tuberculosis bacteria in their system. Given the characteristics of airborne diseases like tuberculosis, coordination among national and...
Read Report
Smiling light-skinned, female-presenting individual with long blonde hair wearing a black shirt on a brown backdrop.

Caitlin MacLean

Managing Director, Innovative Finance, Milken Institute Finance
Caitlin MacLean is a managing director on the innovative finance team at the Milken Institute. She oversees the research, development, execution, and follow-up of our Financial Innovations Labs, which promote financial solutions to overcome economic and social challenges.
Decorative
Power of Ideas

From Care of Disease to Care of the Person

Health-care systems and innovation models have been moving with increased acceleration from a focus on the “care of disease” to the “care and cure of the  person.” Stakeholders have spent nearly 20 years rallying for a reality in which...
Read Essay
A smiling light-skinned female with dark brown hair wearing a black turtleneck against a blurred background

Annalisa Jenkins

Senior Non-Executive Director, Genomics England and Non-Executive Director, Affirmed
Subscribe to Medical Research